Clinical Trial Update: A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ONO-7428 in participants with unresectable advanced or recurrent solid tumors, including non-small cell lung cancer. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ONO-7428

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Solid Tumor, NSCLC | Phase 1 | Status: RECRUITING